Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial

Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a minor release. It reflects a maintenance update rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T04:29:31.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new page revision tag 'Revision: v3.5.3' was added, replacing the previous revision tag. This indicates a version update for the page without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-30T17:52:52.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:58:55.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a condition reference and linked the Genetic and Rare Diseases Information Center under Resources; updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T19:40:21.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:04:30.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    The page shows a new footer revision 'Revision: v3.4.2' and removes the government funding status notice (formerly 'Revision: v3.4.1'). This appears to be a routine site maintenance update with no effect on the study content or results.
    Difference
    0.4%
    Check dated 2026-02-11T05:07:20.000Z thumbnail image

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.